PIAS2 was a protective effect on the prognosis of bladder cancer (OS, DSS), colorectal cancer (DFS, DSS) and brain cancer (OS), but acted as a disadvantage prognostic factor in breast cancer (RFS), lung cancer (OS, RFS) and skin cancer (OS). This evidence concerns the gene PIAS2 and urinary bladder cancer.